Patients
Venous Disease
VENCLOSE™ Procedure
FAQ
Health Professionals
VENCLOSE™ System
Clinical Evidence
Meetings & Events
Resources
About Us
Company
Leadership
Newsroom
Contact Us
Venclose brings in $27 million Series C to market venous reflux solution
December 6, 2019